Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Neuroectodermal Tumors, Primitive, Peripheral

1-methyl-3-isobutylxanthine has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Neuroectodermal Tumors, Primitive, Peripheral: A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mania-Farnell, BL2
Merrill, BJ2
Yamamura, HI1
Davis, TP2
Konings, PN1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Neuroectodermal Tumors, Primitive, Peripheral

ArticleYear
Second messenger activators regulate CCK mRNA in the human neuroepithelioma cell line SK-N-MCIXC.
    Annals of the New York Academy of Sciences, 1994, Mar-23, Volume: 713

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cell Line; Cholecystokinin; Exo

1994
Regulation of CCK mRNA in the human neuroepithelioma cell line SK-N-MCIXC in response to second messenger activators.
    FEBS letters, 1993, Nov-29, Volume: 335, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cell Line; Cholecystokinin; Cyc

1993